Tyra Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tyra Biosciences (Nasdaq: TYRA) announced participation in three investor conferences in May–June 2026: BofA Securities Health Care Conference (virtual fireside chat, May 13, 2026, 10:40 am PT, Las Vegas), TD Cowen Oncology Innovation Summit (virtual fireside chat, May 26, 2026, 2:00 pm ET), and Jefferies Global Healthcare Conference (hybrid, June 3, 2026, 3:45 pm ET, New York).

Access: Live webcasts and replays will be available on the company's For Investors webpage.

News Market Reaction – TYRA

+4.32%

1 alert

+4.32% Session close to close

$2.04B Market Cap

0.0x Rel. Volume

In the May 8 session, TYRA gained 4.32%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CARLSBAD, Calif., May 7, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor conferences:

BofA Securities Health Care Conference 2026
Format: Virtual fireside chat and one-on-one investor meetings
Presentation Date/Time: Wednesday, May 13, 2026 at 10:40 am PT
Location: Las Vegas, NV

TD Cowen's 7^th Annual Oncology Innovation Summit: Insights for ASCO & EHA
Format: Fireside chat with Tyler van Buren
Presentation Date/Time: Tuesday, May 26, 2026 at 2:00 pm ET
Location: Virtual

Jefferies Global Healthcare Conference
Format: Hybrid fireside chat and one-on-one investor meetings
Presentation Date/Time: Wednesday, June 3, 2026 at 3:45 pm ET
Location: New York, NY

A live webcast of the presentations can be accessed by visiting the "For Investors" page on the Tyra Biosciences website and will be available for replay following the event.

About Tyra Biosciences

Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help TYRA design and predict which candidates may demonstrate the highest potency, selectivity and tolerability in the clinic. TYRA's expertise in FGFR biology has created a differentiated pipeline with clinical-stage programs in targeted oncology and genetically defined conditions. TYRA's lead precision medicine stemming from SNÅP, oral dabogratinib, is a potential first-in-class selective FGFR3 inhibitor in development for low-grade upper tract urothelial carcinoma, intermediate risk non-muscle invasive bladder cancer and achondroplasia. TYRA is also developing TYRA-430, an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers, in the SURF431 study for advanced hepatocellular carcinoma, and TYRA-200, an oral, investigational, FGFR1/2/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma. TYRA is based in Carlsbad, CA.

For more information about our science, pipeline and people, please visit www.tyra.bio and engage with us on LinkedIn.

Contact:

Amy Conrad
aconrad@tyra.bio

View original content to download multimedia:https://www.prnewswire.com/news-releases/tyra-biosciences-to-participate-in-upcoming-investor-conferences-302766197.html

SOURCE Tyra Biosciences

FAQ

When will Tyra Biosciences (TYRA) present at the BofA Securities Health Care Conference?

Tyra Biosciences will present on May 13, 2026 at 10:40 am PT in a virtual fireside chat. According to Tyra Biosciences, the session is part of the Las Vegas conference and will include one-on-one investor meetings and a webcast available on the Investors page.

How can investors watch Tyra Biosciences (TYRA) presentations and replays?

Investors can access live webcasts and replays via the company's For Investors webpage. According to Tyra Biosciences, each presentation will be webcast live and recordings will be posted for replay following the events for on-demand viewing by investors.

What is the schedule for Tyra Biosciences (TYRA) at the TD Cowen Oncology Innovation Summit?

Tyra Biosciences will appear on May 26, 2026 at 2:00 pm ET for a virtual fireside chat with Tyler van Buren. According to Tyra Biosciences, the session is part of TD Cowen's summit focused on oncology insights for ASCO and EHA.

Will Tyra Biosciences (TYRA) hold meetings at the Jefferies Global Healthcare Conference?

Yes. Tyra Biosciences will participate in a hybrid fireside chat and one-on-one investor meetings on June 3, 2026 at 3:45 pm ET in New York. According to Tyra Biosciences, the format includes both an in-person presence and virtual accessibility.

Which Tyra Biosciences events are virtual versus in-person in May–June 2026?

The BofA session is virtual (Las Vegas timing), TD Cowen is virtual, and Jefferies is hybrid with an in-person New York component. According to Tyra Biosciences, formats include virtual fireside chats and a hybrid presentation with one-on-one meetings.

What topics will Tyra Biosciences (TYRA) likely cover at these investor conferences?

Presentations will cover the company's clinical-stage programs targeting FGFR biology and corporate updates. According to Tyra Biosciences, the sessions are investor-focused and expected to discuss development progress, program updates, and engagement with analysts and investors.